Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Citi Trends
CTRN
$581M
| $4.14M | 0.01% |
171,204
+22,450
| +15% | +$556K |
|
|
BITA
1502
DELISTED
Bitauto Holdings Limited
BITA
| $4.14M | 0.01% |
81,081
+75,628
| +1,387% | +$4.44M |
|
|
TFM
1503
DELISTED
THE FRESH MARKET, INC COM STK
TFM
| $4.13M | 0.01% |
128,606
-115,640
| -47% | -$4.05M |
|
|
SCLN
1504
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $4.12M | 0.01% |
419,932
-101,200
| -19% | -$922K |
|
1505
PUT
Alibaba
BABA
$286B
| $4.11M | 0.01% |
50,000
| – | – |
|
|
TWTR
1506
DELISTED
Twitter, Inc.
TWTR
| $4.11M | 0.01% |
113,520
-47,206
| -29% | -$1.93M |
|
|
STML
1507
DELISTED
Stemline Therapeutics, Inc.
STML
| $4.11M | 0.01% |
348,980
+15,568
| +5% | +$216K |
|
|
MDRX
1508
CALL
DELISTED
Veradigm Inc. Common Stock
MDRX
| $4.1M | 0.01% |
300,000
+289,200
| +2,678% | +$3.91M |
|
1509
Anika Therapeutics
ANIK
$286M
| $4.1M | 0.01% |
124,224
+74,224
| +148% | +$2.65M |
|
1510
Lesaka Technologies
LSAK
$389M
| $4.1M | 0.01% |
224,436
-131,597
| -37% | -$1.98M |
|
|
TECD
1511
DELISTED
Tech Data Corp
TECD
| $4.1M | 0.01% |
71,286
+59,580
| +509% | +$3.59M |
|
1512
Tetra Tech
TTEK
$9.42B
| $4.1M | 0.01% |
799,090
+228,135
| +40% | +$1.17M |
|
1513
World Kinect Corp
WKC
$1.81B
| $4.09M | 0.01% |
+85,230
| New | +$4.46M |
|
|
ECYT
1514
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $4.07M | 0.01% |
784,407
-25,225
| -3% | -$151K |
|
1515
MidCap Financial Investment
MFIC
$797M
| $4.05M | 0.01% |
+190,710
| New | +$4.42M |
|
|
AIV
1516
Aimco
AIV
$375M
| $4.03M | 0.01% |
819,075
-4,838,038
| -86% | -$24.4M |
|
1517
CALL
KKR & Co
KKR
$96.6B
| $4.03M | 0.01% |
+176,300
| New | +$4.05M |
|
1518
Louisiana-Pacific
LPX
$5.06B
| $4.03M | 0.01% |
+236,495
| New | +$4.02M |
|
1519
Koppers
KOP
$872M
| $4.02M | 0.01% |
+162,640
| New | +$3.94M |
|
1520
WIX.com
WIX
$3.6B
| $4.01M | 0.01% |
169,884
-47,519
| -22% | -$1.08M |
|
1521
Alto Ingredients
ALTO
$309M
| $4.01M | 0.01% |
388,772
-504,112
| -56% | -$5.81M |
|
1522
Medifast
MED
$136M
| $3.99M | 0.01% |
123,534
-10,948
| -8% | -$347K |
|
|
UNTD
1523
DELISTED
UNITED ONLINE INC COM NEW
UNTD
| $3.99M | 0.01% |
254,561
-171,257
| -40% | -$2.83M |
|
|
VG
1524
DELISTED
Vonage Holdings Corporation
VG
| $3.99M | 0.01% |
811,942
-126,622
| -13% | -$609K |
|
1525
State Street Health Care Select Sector SPDR ETF
XLV
$45.5B
| $3.98M | 0.01% |
53,464
-83,172
| -61% | -$6.16M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.